Evidence map›Paper›PMID 30404813›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Gasdermin D Promotes AIM2 Inflammasome Activation and Is Required for Host Protection against

Qifan Zhu, Min Zheng, Arjun Balakrishnan, Rajendra Karki, Thirumala-Devi Kanneganti

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Article
  4. Infection and immunity · 2026
    Article
  5. Article
  6. Review
  7. Role of PANoptosis in intestinal diseases and its therapeutic implications.Journal of molecular medicine (Berlin, Germany) · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Neglected Role of GSDMD C-Terminal in Counteracting Type I Interferon Signaling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Mechanistic insights into gasdermin-mediated pyroptosis.Nature reviews. Molecular cell biology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qifan ZhuDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.ORCID 0000-0001-7174-7943
Min ZhengDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.ORCID 0000-0002-0343-3368
Arjun BalakrishnanDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.
Rajendra KarkiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.
Thirumala-Devi KannegantiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and Thirumala-Devi.Kanneganti@StJude.org.ORCID 0000-0002-6395-6443

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Role of NLR Inflammasomes in Autoinflammatory Diseases and Host DefenseR01AR056296 · NIAMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2008 to 2022
$5.9M
The Non-Inflammasome NLRs in Immunity and Host defenseR01AI124346 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2016 to 2026
$5.8M
Inflammatory Caspases in Innate Immunity and InflammationR37AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2017 to 2026
$4.9M
NLR signaling in colitis and colorectal tumorigenesisR01CA163507 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2020
$3.5M
Inflammatory Caspases in Innate Immunity and InflammationR01AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2016
$2.2M
NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA163507NIAID NIH HHS R01 AI101935NIAID NIH HHS R01 AI124346NIAID NIH HHS R37 AI101935NIAMS NIH HHS R01 AR056296
6 · The paper itself

Abstract

The DNA sensor absent in melanoma 2 (AIM2) forms an inflammasome complex with ASC and caspase-1 in response to

Indexed as

AnimalsApoptosis Regulatory ProteinsCaspase 1Cells, CulturedDNA-Binding ProteinsFemaleFrancisella tularensisGasderminsGram-Negative Bacterial InfectionsInflammasomesInterleukin-18Interleukin-1betaIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMacrophagesMaleAim2 protein, mouseApoptosis Regulatory ProteinsCaspase 1DNA-Binding ProteinsGasderminsGsdmd protein, mouseIL1R1 protein, mouseInflammasomesInterleukin-18Interleukin-1betaIntracellular Signaling Peptides and ProteinsLipopolysaccharidesPhosphate-Binding ProteinsReceptors, Interleukin-1 Type I

Identifiers

PMID30404813
PMCPMC6317867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.